2 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Reconnect Labs: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Effects on Sleep and Safety of RE03 in PTSD Patients With Sleep Disturbances RE03, Placebo - Posttraumatic Stress Disorder (PTSD), Sleep Disturbances and Insomnia | Phase 2 | Completed | Reconnect Labs | 12 | 2025-09-30 | 2026-07-23 |
| Dose-finding PKPD Trial for RE02 in Healthy Subjects RE02, Manitol - Healthy | Phase 1 | Terminated | Reconnect Labs | 4 | 2023-11-20 | 2024-11-27 |
| Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects Dimethyltryptamin (DMT) & Harmine - Healthy | Phase 1 | Completed | Reconnect Labs | 16 | 2023-05-05 | 2023-11-02 |
Parasomnias (1) · Sleep Initiation and Maintenance Disorders (1) · Stress Disorders, Post-Traumatic (1)
Harmine (1) · Mannitol (1) · N,N-Dimethyltryptamine (1)
Switzerland (3)
Erich Seifritz, Prof (2) · Andres Ort, MD (1)